Large brain size is one of the defining characteristics of modern humans. Seckel syndrome (MIM 210600), a disorder of markedly reduced brain and body size 1,2 , is associated with defective ATR-dependent DNA damage signaling 3 . Only a single hypomorphic mutation of ATR has been identified in this genetically heterogeneous condition 4 . We now report that mutations in the gene encoding pericentrin (PCNT)-resulting in the loss of pericentrin from the centrosome, where it has key functions anchoring both structural and regulatory proteins-also cause Seckel syndrome 5, 6 . Furthermore, we find that cells of individuals with Seckel syndrome due to mutations in PCNT (PCNT-Seckel) have defects in ATR-dependent checkpoint signaling, providing the first evidence linking a structural centrosomal protein with DNA damage signaling. These findings also suggest that other known microcephaly genes implicated in either DNA repair responses 7 or centrosomal function 8,9 may act in common developmental pathways determining human brain and body size.
Seckel syndrome is an autosomal recessive disorder of intrauterine growth retardation, severe proportionate short stature and marked microcephaly 1, 2 . The ataxia-telangiectasia and Rad3-related (ATR) gene is mutated in some individuals with Seckel syndrome (ATR-Seckel) 4 , and it encodes a phosphatidylinositol 3-kinase-like kinase that has distinct but overlapping functions with ATM in coordinating the response to DNA damage 10 . ATR is activated by single-stranded DNA, whereas ATM responds to DNA double-strand breaks. MCPH1, encoded by another gene whose mutations cause severe (primary) microcephaly, also acts in the ATR damage response pathway 7 . Furthermore, cell lines of other individuals with Seckel syndrome but without a mutation in ATR also show ATR-pathway dysfunction 3 , suggesting that mutation of additional genes encoding proteins involved in this DNA damage response cascade may also cause this disorder.
To identify such components, we carried out a SNP-microarray Fig. 1 and Supplementary Fig. 2 ). Within this interval were 55 RefSeq-annotated genes, including pericentrin (PCNT), which encodes a centrosomal protein. As mutations in several centrosomal genes, CENPJ, ASPM and CDK5RAP2, cause a related condition, primary microcephaly 8, 9 , we postulated that PCNT might be the causative gene and therefore sequenced its 47 coding exons in affected individuals from both families. We identified a homozygous nonsense mutation in exon 4 of family 1 (E220X). A homozygous single-base pair deletion in exon 12 in family 2 (S629fs; Fig. 1c,d ) led to a frameshift, which was predicted to result in premature protein truncation after an additional 65 amino acids. Both mutations segregated with the disease in each family, with all parents of affected individuals being heterozygous for the respective mutations. From screening of additional cases, we identified a further individual with a homozygous single-base pair insertion in exon 18, resulting in a frameshift at codon 1190 (C1190fs). Neither this insertion nor the other two mutations were present in over 200 control alleles screened. Collectively, these mutations disrupt all described mammalian protein isoforms of PCNT 11, 12 . We therefore concluded that homozygous truncating mutations in PCNT cause Seckel syndrome.
Pericentrin (also known as kendrin) is a huge (360-kDa) coiled-coil protein with a C-terminal PACT domain that targets it to the centrosome (Fig. 1d) . Two protein isoforms have been described in humans 11 : the full-length protein, pericentrin B, and a C-terminally truncated isoform, pericentrin A. Pericentrin localizes to the pericentriolar material (PCM), where it interacts with several structural centrosomal proteins, including γ-tubulin and PCM1 (refs. 13,14) and plays an important role in microtubular nucleation and spindle organization 15, 16 . Antibodies to pericentrin disrupt mitosis, suggesting that it is essential for mitotic progression 15 . However, its Drosophila melanogaster homolog, D-PLP, though required for timely recruitment of PCM components, is apparently dispensable for cell division 17 . Furthermore, in addition to its structural roles, pericentrin acts as a scaffold to recruit signaling proteins, such as protein kinase A (PKA) and protein kinase CβII, to the centrosome 5, 18 .
All mutations identified were homozygous and substantially truncated the protein, suggesting that they are functionally 'null' alleles. To test this prediction, we examined pericentrin localization in lymphoblastoid cell lines (LCLs) of affected individuals. Centrosomal pericentrin staining was lost in three independent LCLs, in contrast to control cell lines ( Fig.  2a and Supplementary Fig. 3 online), both in interphase and mitosis. We also examined protein expression by immunoblotting (Fig. 2b) . Two bands were detected in controls (wild-type (WT) and heterozygous relatives (PCNT E220X/+ and PCNT S629fs/+ )), representing two isoforms of pericentrin, which were not present in mutant LCLs. A smaller ~170-kDa band was present in PCNT E220X lymphoblastoid cells (potentially representing an aberrant truncated PCNT protein product), whereas no significant PCNT protein was apparent in the other two mutant cell lines, supporting the molecular genetic findings that protein function is considerably, if not completely, disrupted. We next examined other components of the centrosome in order to establish whether they were affected by the absence of pericentrin. ASPM, PCM-1, ninein and centrin were all localized normally ( Fig. 2a and Supplementary Fig. 4 online) . However, during mitosis, γ-tubulin was significantly reduced or absent at prometaphase and metaphase (Fig. 2c,d) , consistent with the results of previous RNAi experiments 6 .
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Other individuals with Seckel syndrome have defects in the ATR DNA damage response pathway 3 . We therefore assessed PCNT-Seckel cell lines to see whether loss of this key centrosomal protein is associated with the defects in ATR signaling previously described for this disorder 3, 4 . Indeed, PCNT-Seckel (PCNT C1190fs , PCNT E220X and PCNT S629fs ) LCLs showed defective UV-induced G2-M checkpoint arrest, similar to that seen in ATR-Seckel LCLs (Fig. 3a) , in contrast to cell lines established from heterozygote relatives (PCNT E220X/+ , PCNT S629fs/+ ) and an unrelated WT control. This suggested that mutations in PCNT affect ATR-dependent cell cycle checkpoint activation. Similarly, PCNT-Seckel LCLs also showed elevated nuclear fragmentation after replication-fork stalling (Fig. 3b) and supernumerary mitotic 'centrosomes' after prolonged mitotic arrest with nocodazole (Fig. 3c) , two additional cellular phenotypes caused by impaired ATR signaling 3 .
As these findings suggested a direct role for PCNT in ATR-dependent DNA damage response signaling, we examined further steps in this signaling cascade in PCNT-Seckel cells. We found that ATR-dependent γH2AX formation was normal in PCNT-Seckel LCLs, similar to controls (Fig. 3d) . This was distinct from what was observed in ATR-Seckel LCLs and suggested that ATR is able to phosphorylate a key substrate in PCNT-Seckel cells. Thus, pericentrin functions downstream of ATR kinase activation in this pathway.
We next examined hydroxyurea-induced 53BP1 foci formation in PCNT-Seckel cell lines. Notably, both PCNT-Seckel and ATR-Seckel LCLs did not form such foci, in contrast to control cell lines (Fig. 3e) . This phenotype is dependent on both ATR and Chk1 kinases 19 , indicating that PCNT has a downstream role in ATR-pathway function.
To determine whether PCNT mutations affect other DNA damage responses, we assessed the G2-M checkpoint response to DNA doublestrand breaks induced by ionizing radiation. This response is specifically dependent on ATM and not ATR signaling. PCNT-Seckel LCLs arrested as efficiently as control LCLs under these conditions. ATRSeckel LCLs, unlike ATM-mutant LCLs, also had a normal response, confirming that this assay was ATR independent (Fig. 3f) . Therefore, we concluded that mutations in PCNT have specific effects on the downstream stage of the ATR pathway, including G2-M checkpoint activation. We also carried out siRNA experiments in HeLa cells to provide confirmatory evidence that PCNT is required for ATR-dependent signaling. siRNA depletion of PCNT also results in defective ATR-dependent (UV) checkpoint activation ( Supplementary Fig. 5 online), as we had observed in PCNT-Seckel LCLs. Furthermore, we did not find any defects in ATM-dependent checkpoint response after ionizing radiation. These results substantiate our findings indicating that PCNT mutations cause impaired ATR signaling.
PCNT is a key structural centrosomal protein nucleating microtubular assembly during mitosis 15, 16 . It was thus surprising to identify homozygous truncating mutations that seem to cause absence of known forms of PCNT protein from centrosomes. So, notably, PCNT would seem to be dispensable for most aspects of human development. Pericentrin mutations do, however, markedly reduce both body and brain size by ~8 s.d. below the norm. Other centrosomal genes (ASPM, CDK5RAP2 and CENPJ) have been implicated in determining human brain size, as they are mutated in primary microcephaly. They are presumed to act through effects on neurogenic mitosis 8, 9, 20 , perhaps modulating symmetric versus asymmetric cell division. Given the role of PCNT in mitotic spindle assembly 15, 16 , perturbation of cell division may similarly result in globally reduced cell number, thus additionally causing reduced body size. However, for the ATR, MCPH1 and now PCNT genes, there is a specific correlation between defects in ATR signaling and reduced brain and body size 4, 7 . This suggests an alternative explanation-impaired ATR signaling might cause these phenotypes directly, through impaired mitotic progression or reduced cell survival.
Primary microcephaly genes have undergone considerable adaptive evolution in primates, suggesting that functional alterations in the proteins they encode may have contributed to the evolution of human brain size 21 . Morphologically, Seckel syndrome also has evolutionary parallels. Homo floresiensis, the recently described Indonesian hominid, has similarly marked reduced brain and body size (cranial volume -6.1 s.d, height -9.5 s.d, relative to modern humans) 22 . Consequently, changes in PCNT or similar genes could underlie the anatomical differences seen in this hominid 23 .
By studying a human disease phenotype, we have, for the first time, implicated a structural protein of the centrosome in the ATR-dependent DNA damage response. Centrosomes have a central role in regulating cell cycle progression 24 , and pericentrin has an established role in recruiting regulatory proteins to the centrosome 5, 18 . Therefore, a role in checkpoint signaling would be consistent with its known functions. Components of the ATR pathway have been observed to localize to the centrosome 25 , most notably Chk1 (refs. 26,27) . Chk1 centrosomal localization, mediated by activating phosphorylation at Ser317 and Ser345 residues 28 , is enhanced by DNA damage. At the centrosome, Chk1 is thought to delay G2-M transition through inhibiting activation of Cyclin B-Cdk1 by Cdc25 (ref. 27) . Notably, fusion of Chk1 with a PACT domain prevents G2-M mitotic progression 27 , suggesting that endogenous pericentrin, one of only two PACT domain containing proteins, could provide the means of Chk1 localization to mediate G2-M checkpoint arrest (model , Fig. 4) . Alternatively, PCNT may not be required for localization of Chk1, but may be necessary for Chk1 to transmit its signal to downstream centrosomally localized components to effect G2-M arrest. Future investigations based on these possibilities will be valuable in understanding the mechanism of Chk1 relocalization and activation at the centrosome.
The identification of pericentrin mutations in Seckel syndrome also provides an interesting convergence between microcephaly genes implicated in ATR signaling (MCPH1 and ATR) and those involved in centrosomal function (ASPM, CDK5RAP2 and CENPJ). This suggests that further biochemical and developmental investigation is likely to be fruitful in delineating common cellular pathways responsible for the brain and body size phenotypes in these syndromes.
METHODS
Affected individuals with Seckel syndrome. All affected individuals included in this study were diagnosed with Seckel syndrome and had intrauterine growth retardation, severe proportionate short stature, marked microcephaly and developmental delay. Blood samples were obtained with informed consent from affected children, parents and unaffected siblings. We established lymphoblastoid cell lines by EBV transformation and extracted genomic DNA using standard methods. The study was approved by the Scottish Multicentre Research Ethics Committee (04:MRE00/19) and the University of Sussex School of Life Sciences Research Governance Committee.
Genotyping and linkage analysis. SNP microarray genotyping was done by AROS Applied Biotechnology (Denmark) using Affymetrix Human Mapping 50K Xba240 Genechips. We analyzed SNP genotypes using Alohomora 29 and carried out multipoint linkage with GENEHUNTER (version 2.0β) under a model of autosomal recessive inheritance with full penetrance, using a disease-allele frequency estimated at 1 in 1,000. We used deCODE genetic map distances and Affymetrix SNP allele frequencies.
Mutation detection. We designed primers using the ExonPrimer tool in the University of California Santa Cruz Genome Browser to amplify coding exons of pericentrin (primer sequences listed in Supplementary Table 1 online). Purified PCR amplification products were sequenced using dye-terminator chemistry and electrophoresed on an ABI 3730 capillary sequencer (Applied Biosystems). Mutation analysis was done using Mutation Surveyor (Softgenetics). Anonymous control samples were screened by sequencing.
Cell lines and cell culture. LBLs were cultured in RPMI 1640 with 15% FCS (FCS). We used wild-type (WT; GM02188), ATR-Seckel (DK0064) and ataxia telangiectasia-mutated (ATM; GM03189D) cell lines, all of which have been described previously 4, 7 . PCNT E220X (cell-line identifier: CV1559; affected Seckel, PCNT 658G>T); PCNT E220X/+ (cell-line identifier: CV1584; unaffected brother of CV1559); PCNT S629fs (cell-line identifier: CV1576; affected Seckel, PCNT 1887delA); PCNT S629fs/+ (cell-line identifier: CV1582; unaffected mother of CV1576) and PCNT C1190fs (12061; affected Seckel, PCNT 3568_3569insT). Model of pericentrin's role in ATR-dependent G2-M checkpoint arrest. Low-dose UV and hydroxyurea activate ATR kinase, which then phosphorylates downstream targets including Chk1 kinase. Activating phosphorylation is required for accumulation of Chk1 at the centrosome after DNA damage 28 . Direct or indirect binding of Chk1 by pericentrin could mediate localization of Chk1 to the centrosome. Chk1 localization at the centrosome inhibits Cdc25, preventing cyclin B/Cdk1 activation 27 and thus the transition from G2 to mitosis.
Immunofluorescence and protein blotting. Immunostaining was done as previously described 30 . We used antibodies at the following dilutions: antipericentrin (Abcam, ab448-100) Sedat filter set driven by SoftWorx software under standard conditions. All images were archived as raw (r3d) and deconvolved (d3d) files. Images were subjected to standard deconvolution algorithm. Three-dimensional datasets were converted to Quick Projections in SoftWorx and then converted to TIFF files and imported into Adobe Photoshop for final presentation. For the quantification of γ-tubulin staining in mitosis, we used a defined volume containing the centrosome to measure the total intensity of the signal. The same volume was used to identify the background noise as intensity outside the cells and also the non-centrosomal γ-tubulin within the cells. We averaged the ratios of centrosome-bound and dispersed γ-tubulin for each slide after background subtraction and calculated the relative intensity in comparison to the WT control slide.
Immunoblotting was done using anti-pericentrin (Abcam, ab448-100) at 1:1,000, and horseradish peroxidase (HRP)-conjugated anti-rabbit IgG secondary antibody, 1:5,000 (Cell Signaling 7074), detected with ECL-Plus (Amersham).
DNA damage response assays. For ATR-dependent G2-M arrest, cells were untreated (UNT) or irradiated with 5 J/m 2 UV-C (UV) and immediately seeded into complete medium and incubated for 2 h before being cytospun onto poly-D-lysine-coated slides and stained with 4,6-diamidino-2-phenylindole (DAPI) and anti-phospho-histoneH3, as previously described 7 . For the ATM-dependent G2-M arrest, cells were either untreated (UNT) or irradiated with 2 Gy of ionizing radiation (IR) and processed as above. For γH2AX formation and 53BP1 foci formation, cells were either untreated (UNT) or treated with 5 mM hydroxyurea (HU) for 2 h and processed for immunofluorescence (IF) staining as previously described 3 . Cells were also pulse labeled (15 min) with 50 µM BrdU to allow quantification of cells in S phase using anti-BrdU by immunofluorescence. Supernumerary mitotic centrosomes were determined after treatment with 1.5 µM nocodazole for 24 h as previously described 7 . We used the following antibodies: anti-γH2AX (Upstate Technology), anti-53BP1 (BL181; Universal Biologicals), anti-BrdU (Autogen Bioclear) and anti-γ-tubulin (Sigma-Aldrich).
RNAi. HeLa cells were transfected with 10 nmol of Invitrogen Stealth duplex oligoribonucleotides using siPORT NeoFX Transfection Agent (Ambion, standard protocol). siRNA oligonucleotide sequences are listed in Supplementary Table 1 . After 72 h, we carried out G2-M checkpoint assays, as outlined above.
